News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement

Matt Cutler

Advertisement

Articles by Matt Cutler

Shifting Patent Litigation Trends Favor Branded Pharma Companies

ByMatt Cutler
August 20th 2019

The latest trends in patent litigation has led to a more harmonized patent system, which can benefit pharmaceutical companies that invest in patents.

Advertisement

Latest Updated Articles

  • Shifting Patent Litigation Trends Favor Branded Pharma Companies
    Shifting Patent Litigation Trends Favor Branded Pharma Companies

    Published: August 20th 2019 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report

2

Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings

3

FDA Announces New Biosimilar-Targeted Draft Guidance

4

Lilly Forms Partnership with NVIDIA to Create AI Supercomputer

5

Pharmaceutical Executive Daily: Lilly and NVIDIA Create AI Supercomputer

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us